IGF-1 activity is reported to be negatively controlled by the action of PTP1B [27] and inhibiting PTP1B is considered to have neuroprotective effects in diabetic retinopathy by modulating IGF-1 activity [28]. The gene discussed is PTPN1; the disease is diabetic retinopathy.